PLoS ONE (Nov 2010)

Angiogenin levels and ANG genotypes: dysregulation in amyotrophic lateral sclerosis.

  • Russell Lewis McLaughlin,
  • Julie Phukan,
  • William McCormack,
  • David S Lynch,
  • Matthew Greenway,
  • Simon Cronin,
  • Jean Saunders,
  • Agnieska Slowik,
  • Barbara Tomik,
  • Peter M Andersen,
  • Daniel G Bradley,
  • Phil Jakeman,
  • Orla Hardiman

DOI
https://doi.org/10.1371/journal.pone.0015402
Journal volume & issue
Vol. 5, no. 11
p. e15402

Abstract

Read online

ObjectiveTo determine whether 5 single nucleotide polymorphisms (SNPs) associate with ALS in 3 different populations. We also assessed the contribution of genotype to angiogenin levels in plasma and CSF.MethodsAllelic association statistics were calculated for polymorphisms in the ANG gene in 859 patients and 1047 controls from Sweden, Ireland and Poland. Plasma, serum and CSF angiogenin levels were quantified and stratified according to genotypes across the ANG gene. The contribution of SNP genotypes to variance in circulating angiogenin levels was estimated in patients and controls.ResultsAll SNPs showed association with ALS in the Irish group. The SNP rs17114699 replicated in the Swedish cohort. No SNP associated in the Polish cohort. Age- and sex-corrected circulating angiogenin levels were significantly lower in patients than in controls (pConclusionsANG variants associate with ALS in the Irish and Swedish populations, but not in the Polish. There is evidence of dysregulation of angiogenin expression in plasma and CSF in sporadic ALS. Angiogenin expression is likely to be important in the pathogenesis of ALS.